SENDA BIOSCIENCES

Senda Biosciences is a developer of therapeutic applications intended for novel treatments of human disease. The company studies the molecular relationships between bacterial, botanical, and human cells as well as how they define health and disease, providing medical professionals with novel medications and delivery methods. Senda Biosciences was established in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts.

SENDA BIOSCIENCES

Social Links:

Twitter

Industry:

Biotechnology Health Care Life Science

Founded:

2017-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.sendabiosciences.com

Total Employee:

51+

Status:

Active

Contact:

617-430-4455

Email Addresses:

[email protected]

Total Funding:

309 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Nginx Euro Organization Schema CloudFront PostalAddress Schema LocalBusiness Schema

Similar Organizations

hc-bioscience-logo

hC Bioscience

hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system

Current Advisors List

luis-cantarell_image

Luis Cantarell Member Board Of Directors @ Senda Biosciences
Board_member
2018-02-01

Current Employees Featured

guillaume-pfefer_image

Guillaume Pfefer
Guillaume Pfefer Chief Executive Officer @ Senda Biosciences
Chief Executive Officer

david-kolesky_image

David Kolesky
David Kolesky Co-founder @ Senda Biosciences
Co-founder
2017-01-01

ignacio-martinez_image

Ignacio Martinez
Ignacio Martinez Co-Founder, Chairman of the Board @ Senda Biosciences
Co-Founder, Chairman of the Board
2018-11-01

kyle-chiang_image

Kyle Chiang
Kyle Chiang Chief Scientific Officer @ Senda Biosciences
Chief Scientific Officer

john-casey_image

John Casey
John Casey Co-Founder, Vice President, Head of Business Development @ Senda Biosciences
Co-Founder, Vice President, Head of Business Development
2017-01-01

stuart-milstein_image

Stuart Milstein
Stuart Milstein SVP and Head of Platform Biology @ Senda Biosciences
SVP and Head of Platform Biology
2022-01-01

matthew-osborne_image

Matthew Osborne
Matthew Osborne Chief Financial Officer @ Senda Biosciences
Chief Financial Officer
2021-06-01

ilya-rekhter_image

Ilya Rekhter
Ilya Rekhter Investor @ Senda Biosciences
Investor
2019-09-01

Founder

david-kolesky_image

David Kolesky

ignacio-martinez_image

Ignacio Martinez

john-casey_image

John Casey

Acquisitions List

Date	Company	Article	Price
2020-10-28	Kintai Therapeutics	Kintai Therapeutics acquired by Senda Biosciences	N/A
2020-08-01	Omega Therapeutics	Omega Therapeutics acquired by Senda Biosciences	N/A

Investors List

ischyros-new-york_image

Key Employee Changes

Date	New article
2022-01-26	Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology

Official Site Inspections

http://www.sendabiosciences.com Semrush global rank: 3.68 M Semrush visits lastest month: 3.8 K

Host Informations
Whois Informations

Loading ...